Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Insider's Gabby Landsverk"


2 mentions found


But she knows — from experience — that probably won't be possible if she has to stop taking the drug once her manufacturer-issued coupons expire. But the injections don't work once people stop taking them. Li Ran/Xinhua via Getty ImagesMany health insurers and employers have long declined to pay for weight-loss drugs. He has resumed taking weight-loss medication but said he hoped to go down to a lower dose. Want to tell us about your experience with health insurance and weight-loss drugs?
Persons: Tara Rothenhoefer, Rothenhoefer, Eli Lilly's, Insider's Gabby Landsverk, , Wegovy, Rothenhoefer Novo, we're, Dr, Martin Lange, Novo, Eli Lilly, Li Ran, Sean Duffy, Omada, Duffy, hungrier, Nisha Patel, it's, " Lange, Bill, Gabby Landsverk, Shelby Livingston, Hilary Brueck Organizations: Rothenhoefer Novo Nordisk, Novo Nordisk, Getty, National Library of Medicine Locations: San Francisco, Novo, Xinhua, slivingston
Analysts at UBS said Eli Lilly is their top Big Pharma stock pick. They said Lilly's obesity and diabetes drug Mounjaro will likely top Wall Street's sales estimates. The experimental Alzheimer's drug lecanemab could help boost the stock too. Lilly's stock gained 3.2% to $305.80 on Thursday morning. They also touted the potential of Lilly's experimental Alzheimer's drug donanemab, saying it has a 60% chance of success.
Total: 2